SPY322.64-7.66 -2.32%
DIA267.58-5.23 -1.92%
IXIC10,632.99-330.65 -3.02%

Galera Therapeutics Reports Dosing Of First Patient In Phase 2a Trial Of Avasopasem Manganese In Second Indication

Benzinga · 01/07/2020 21:40